S66.AU Star Combo Pharma Ltd

Consumer Defensive Personal Care Products Australian Securities Exchange
0.1400 AUD
Close of Oct 31, 2026
0.1077 0.2692
Market cap
AUD 18.9M
P/E
-
P/B
0.49x
ROE
1.0%
Dividend yield
2.11%
Fundamental score
1.6/5

Ratios use the latest price and the fiscal year ending Jun 2026.

Is S66.AU undervalued?

Graham number

The Graham number of Star Combo Pharma Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Star Combo Pharma Ltd fundamental analysis

8 of 22 checks passed

ROE 0/2

Low return on equity (1.0%), below 10%.

ROA 1/1

Return on assets (0.8%) is above the industry median (-30.2%).

Profit Consistency 1/2

Profitable for 3 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Last year's EPS growth (-92.5%) is below the industry median (-11.1%).

Revenue Growth 0/2

Revenue shrank 1.5% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (10.8%), 40% or less.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 0/1

EBIT is negative, against interest expense, below 5x.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 1/1

Price to book (0.5x) is below the industry median (6.8x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

Dividend yield cannot be calculated.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

Payout ratio is 126.7%, above 90% of earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Star Combo Pharma Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Star Combo Pharma Ltd

Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company engages in the development, manufacturing, marketing, and sale of natural health supplements and skin care products and provision of Chinese health products through its e-commerce platform. It sells its products under the Living Healthy, Costar, Amax, and J&K brands. Star Combo Pharma Limited …

Full company profile